We analyzed the mRNA expression levels of AACT and found that AACT expression was associated with the overall survival of liver cancer in 333 patients, and decreased expression of AACT was associated with poorer survival of patients with liver cancer (Fig. 6A). Here, SERPINA3 is linked to liver cancer.